Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.221EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.362ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.216NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.216NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.471ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.471ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.471SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.471SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.471EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.471EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.471NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.471NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.16ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
C.16ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
C.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
C.16SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
C.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.420ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.1.420ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.420SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.1.420SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.1.420EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.420NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.420NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
L.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
L.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
L.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
L.3SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
L.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
L.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
L.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.36ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.36SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
B.1.36SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
B.1.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.518ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
B.1.518ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used